Cryosupernatant

Cryosupernatant (pronunciation: /ˌkraɪoʊˌsuːpərˈnætənt/) is a term used in the field of medicine and hematology to refer to the supernatant fluid that remains after the freezing and thawing of plasma.

Etymology

The term 'Cryosupernatant' is derived from the Greek word 'kryos' meaning 'cold', and the Latin word 'supernatant' meaning 'floating on top'. It refers to the fluid that floats on top after the freezing and thawing process of plasma.

Usage

In medical practice, Cryosupernatant is often used in the treatment of Thrombotic Thrombocytopenic Purpura (TTP), a rare blood disorder. It is also used in the treatment of Hemophilia as it contains high levels of fibrinogen, a protein that helps in blood clotting.

Related Terms

Plasma: The liquid component of blood in which the blood cells are suspended.
Fibrinogen: A protein produced by the liver, which helps in the clotting of blood.
Thrombotic Thrombocytopenic Purpura (TTP): A rare disorder that causes blood clots to form in small blood vessels throughout the body.
Hemophilia: A medical condition in which the ability of the blood to clot is severely reduced, causing the sufferer to bleed severely from even a slight injury.

External links

Medical encyclopedia article on Cryosupernatant
Wikipedia's article - Cryosupernatant

This WikiMD dictionary article is a stub. You can help make it a full article.

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

Cryosupernatant